by Randi Fredricks, Ph.D. | Jun 19, 2023 | Addiction, Anxiety Treatment, Complementary and Alternative Medicine, Depression, Psychotherapy |
In October 2019, the U.S. Food and Drug Administration (FDA) approved esketamine, a substance chemicallyrelated to the party drug ketamine, as a nasal spray to treat depression (Bahr, 2019). The effectiveness of ketamine for depression was first shown in studies in...
by Randi Fredricks, Ph.D. | Jul 11, 2020 | Anxiety Treatment, Complementary and Alternative Medicine, Psychotherapy, PTSD, Stress Management |
Targeting Anxiety at its Core: The Clinical Emergence of Psychedelic-Assisted Therapy In 2018, researchers from Johns Hopkins University recommended that psilocybin (the active compound in magic mushrooms) be reclassified for medical use, paving the way for the...
